A new engagement report from Noom highlights the significant impact of using their platform in conjunction with GLP-1 medications for weight loss. According to the data, patients who actively participate in Noom’s programs tend to lose more weight compared to those who do not. Moreover, these engaged users maintain their medication regimen for extended periods, ensuring better overall health outcomes. Noom’s innovative approach combines personalized coaching and technology, which not only helps in effective weight management but also fosters sustainable lifestyle changes. This finding underscores the potential of integrating digital health tools with traditional medical treatments to enhance patient success rates. For individuals on a GLP-1 plan, following Noom’s guidelines can be a transformative approach to achieving their weight loss goals. Overall, this report advocates for the growing relevance of digital health interventions in medical programs.
GlobeNewswireNew data shows 6 Million Canadians Affected by Heart Disease or Stroke
February 6, 2026
Recent statistics reveal a startling insight: 6 million Canadians are currently living with heart disease or stroke. This significant number underscores the widespread impact of